Governmentality and risk: Setting priorities in the new NHS

Sociology of Health and Illness

Volumn 23, Issue 5, 2001, Pages 594-614

  Joyce, Paul ^a  

^a UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

Governmentality; NHS; Rationing; Risk; Interferon

Indexed keywords

EID: 0035438117     PISSN: 01419889     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-9566.00267     Document Type: Article

References (40)

1. Appleby, J. (1994) Developing Contracting: a National Survey of District Health Authorities, Boards and NHS Trusts. Research Paper 15. Birmingham: NAHAT.
2. Appleby, J., Little, V., Ranadé, W., Robinson R. and Smith P. (1992) Implementing the Reforms: a Second National Survey of District General Managers. Project Paper 7. Birmingham: NAHAT.
3. Ashmore, M., Mulkay, M. and Pinch, T. (1989) Health and Efficiency: a Sociology of Health Economics. Buckingham: Open University Press.
4. Ashton, J. and Seymour, H. (1988) The New Public Health. Milton Keynes: Open University Press.
5. Audit Commission (1996) Funding Facts. London: HMSO.
6. Burchell, G., Gordon, C. and Miller, P. (eds) (1991) The Foucault Effect: Studies in Governmentality. Hemel Hempstead: Harvester Wheatsheaf.
7. Burnfield, A (1997) Reducing frequency and severity of relapses will be of great clinical benefit, British Medical Journal, 314, 600.
8. Cardy, P. (1997) Relapses deserve treatment, British Medical Journal, 314, 600.
9. Crail, M. (1995) Rational judgements, Health Service Journal, 105, 12.
10. Department of Health (1997) The New NHS: modern, dependable, London: HMSO.
11. Department of Health (1989) Working for Patients, Cmnd. 855. London: HMSO.
12. Drug Therapeutics Bulletin (1996) Interferon Beta 1b - Hope or Hype?, 34, 9-11.
13. Dunham, P. and Smith, S. (1993) The changing role of the CHCs, Health Service Management, May, 14-16.
14. Flynn, R. (1997) 'Governmentality' and Determinacy in quasi Market Contracting. Paper presented at British Sociological Annual Conference, York, 7-10 April.
15. Foucault, M. (1973) The Birth of the Clinic: an Archaeology of Medical Perception. New York: Pantheon Books.
16. Freemantle, N. and Harrison, S. (1993) Interleukin-2: the public and professional face of rationing in the NHS, Critical Social Policy, 13, 3, 94-117.
17. Freemantle, N., Watt, I. and Mason, J. (1993) Developments in the purchasing process in the NHS: towards an explicit politics of rationing?, Public Administration, 71, 535-48.
18. Gordon, C. (1991) Government rationality: an introduction. In Burchell, G., Gordon, C. and Miller, P. (eds) The Foucault Effect: Studies in Governmentality. Hemel Hempstead: Harvester Wheatsheaf.
19. Ham, C. (1994) Management and Competition in the New NHS. Oxford: Radcliffe Medical Press.
20. Harvey, P. (1996) Why interferon beta 1b was licensed is a mystery, British Medical Journal, 313, 297.
21. Hughes, D. and Griffiths, L. (1999) On penalties and the Patient's Charter: centralism v decentralised governance in the NHS, Sociology of Health and Illness, 21, 1, 71-94.
22. Hunter, D. (1993) Rationing Dilemmas in Healthcare. Birmingham: NAHAT.
23. Klein, R., Day, P. and Redmayne, S. (1996) Managing Scarcity: Priority Setting and Rationing in the NHS. Buckingham: Open University Press.
24. Light, D.W. (2001) Comparative institutional response to economic policy managed competition and governmentality, Social Science and Medicine, 52, 8, 1151-66.
25. McDonald, W.I. (1995) New treatments for multiple sclerosis, British Medical Journal, 310, 345-6.
26. McQueen, D. (1989) Thoughts on the ideological origins of Health Promotion, Health Promotion, 4, 4, 339-42.
27. New, B. (1996) The rationing agenda in the NHS, British Medical Journal, 312, 1593-601.
28. NHS Executive (1995) New Drugs for Multiple Sclerosis EL(95)97. Leeds: Department of Health.
29. O'Malley, P. (1992) Risk, power and crime prevention, Economy and Society, 21, 3, 252-75.
30. Osborne, T. (1997) Of health and statecraft. In Petersen, A. and Bunton, R. (eds) Foucault, Health and Medicine. London: Routledge.
31. Paton, C. (1996) Health Policy and Management: the Health-care Agenda in a British Political Context. London: Chapman and Hall.
32. Ranadé, W. (1995) The theory and practice of managed competition in the National Health Service, Public Administration, 73, 241-62.
33. Redmayne, S. (1995) Reshaping the NHS: Strategies, Priorities and Resource Allocation, Research Paper No. 16. Birmingham: NAHAT.
34. Redmayne, S., Klein, R. and Day, P. (1993) Sharing Out Resources: Purchasing and Priority Setting in the NHS, Research Paper No. 11. Birmingham: NAHAT.
35. Richards, R. G. (1996) Interferon beta in multiple sclerosis: Clinical cost effectiveness falls at the first hurdle, British Medical Journal, 313, 1159.
36. Rose, N. (1993) Government, authority and expertise in advanced liberalism, Economy and Society, 22, 3.
37. Rose, N. and Miller, P. (1992) Political power beyond the state: problematics of government, British Journal of Sociology, 43, 2, 173-205.
38. Rous, E., Coppel, A., Hayworth, J. and Noyce, S. (1996) A purchaser experience of managing new expensive drugs: interferon beta, British Medical Journal, 313, 1195-6.
39. Smart, B. (1986) The politics of truth and the problem of hegemony. In Hoy, D. C. (ed) Foucault: a Critical Reader. Oxford: Blackwell.
40. Smee, C. (1995) Self-governing trusts and GP fundholders: the British experience. In Saltman, R. and Von Otter, C. (eds) Implementing Planned Markets in Health Care. Buckingham: Open University Press.